Posted by Michael Wonder on 08 Mar 2016

Scotland rejects cancer drugs Opdivo and Perjeta

Pharmaphorum

7 March 2016 - The SMC has rejected Opdivo as a monotherapy for the treatment of advanced melanoma, and Perjeta for treatment of early stage breast cancer.

For more details, go to: http://www.pharmaphorum.com/news/scotland-rejects-cancer-drugs-opdivo-and-perjeta?utm_medium=nl&utm_source=internal&mkt_tok=3RkMMJWWfF9wsRokuarBe%2B%2FhmjTEU5z17%2BkqUKG3iokz2EFye%2BLIHETpodcMScdjNrvYDBceEJhqyQJxPr3HJdQN18R7RhHnDg%3D%3D

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Cancer , Outcome , Medicine , Health technology assessment , Scotland